Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

CYT-0853, a Novel RAD51 Inhibitor, Modulates Immunoregulatory B-Lymphocytes

Tamar Aprahamian, PhD, ED Keniston, Jane Branca, Muneer G Hasham, PhD, Melinda Day, PhD, Kevin Mills, PhD

Blood (2019) 134 (Supplement_1): 2330.

https://doi.org/10.1182/blood-2019-131311

Published: 2019

Journal Articles

ZAP-70 Expression in Non Tumoral B Cells: Role in B Tolerance Breakdown?

Mickaël Martin, MD PhD, Anne Marie Knapp, Dana Ghergus, MD PhD, Fabien Delmotte, Laurent Vallat, MD PhD, Cédric Schleiss, Raoul Herbrecht, MD, Anne-Sophie Korganow, MD PhD, Frédéric Gros, PhD, Sophie Jung, DMD, PhD, Pauline Soulas-Sprauel, PharmD, PhD, Eric Meffre, PhD, Thierry Martin, MD PhD

Blood (2018) 132 (Supplement 1): 1114.

https://doi.org/10.1182/blood-2018-99-118237

Published: 2018

Journal Articles

Targeting Putative Mu Opioid/Chemokine Receptor Type 5 Heteromers Potently Attenuates Nociception in a Murine Model of Sickle Cell Disease

Giuseppe Cataldo, PhD, Mary M. Lunzer, MA, Donald A. Simone, PhD, Eyup Akgün, PhD, John D. Belcher, PhD, Gregory M Vercellotti, Philip S. Portoghese, PhD

Blood (2015) 126 (23): 277.

https://doi.org/10.1182/blood.V126.23.277.277

Published: 2015

Journal Articles

Sustained Elevation of Adenosine-ADORA2B Signaling Promotes Chronic Pain through Neuro-Immune Interaction in Sickle Cell Disease

Morayo G. Adebiyi, BS, Xia Hu, MD, Jialie Luo, PhD, Kaiqi Sun, BS, Thanh-Thuy T. Le, MD PhD, Yujin Zhang, MD, Hongyu Wu, PhD, Hong Liu, MD, Aji Huang, BS, MS, Rodney E. Kellems, PhD, Michael R. Blackburn, PhD, Edgar T. Walters, PhD, Hongzhen Hu, PhD, Yang Xia, MD PhD

Blood (2015) 126 (23): 974.

https://doi.org/10.1182/blood.V126.23.974.974

Published: 2015

Journal Articles

Preclinical Development Of ROR1 Peptide Based Vaccine With Activity Against Chronic Lymphocytic Leukemia In ROR1 Transgenic Mice

Jian Yu, PhD, Bing Cui, Ph.D., George F. Widhopf, II, PhD, Liguang Chen, MD, PhD, Laura Rassenti, PhD, Zhengran Wang, BS, Shuyu Ma, BS, Tomoko Hayashi, M.D., Ph.D., Dennis A. Carson, M.D., Thomas J. Kipps, MD, PhD

Blood (2013) 122 (21): 4174.

https://doi.org/10.1182/blood.V122.21.4174.4174

Published: 2013

Journal Articles

Hepcidin Independent Anemia of Inflammation

Seth Rivera, M.D., Ph.D., Sophie Vaulont, Ph.D., Dana Shprung, Donald Limbrick, Tomas Ganz, MD, PhD

Blood (2010) 116 (21): 2050.

https://doi.org/10.1182/blood.V116.21.2050.2050

Published: 2010

Journal Articles

Leukemia Free Survival Is Associated with Presence of Leukemia Reactive Antibodies In Allogeneic Transplant Recipients

Craig A. Mullen, MD, PhD, Yu-Chiao Hsu, MS, Andrew Campbell, MS, Johan Jansson, Ph.D., Olena Tkachenko, M.D.

Blood (2010) 116 (21): 2534.

https://doi.org/10.1182/blood.V116.21.2534.2534

Published: 2010

Journal Articles

Tissue Damage and Lymphoma Derived Chemoattractive Signals Impact Regulatory T Cell Trafficking After Allogeneic Hematopoietic Cell Transplantation.

Christoph Dürr, Dietmar Pfeifer, PhD, Annette Schmitt-Gräff, Rainer Claus, Ulrike Gerlach, Ralph Graeser, Armin Gerbitz, MD, Robert Negrin, Jürgen Finke, Robert Zeiser, MD

Blood (2009) 114 (22): 3564.

https://doi.org/10.1182/blood.V114.22.3564.3564

Published: 2009

Journal Articles

Cannabinoids as Analgesics for Pain in Sickle Cell Disease.

Divyanshoo Rai Kohli, Yunfang Li, MD, Sergey G Khasabov, Marna E Ericson, Pankaj Gupta, MD, Donald A Simone, Robert P Hebbel, MD, Kalpna Gupta, PhD

Blood (2009) 114 (22): 822.

https://doi.org/10.1182/blood.V114.22.822.822

Published: 2009

Journal Articles

Hyperactivable NFAT1 Ameliorates Autoimmune Encephalitis In Vivo.

Srimoyee Ghosh, PhD, Sergei B Koralov, PhD, Irena Stevanovic, MD, Mark S Sundrud, PhD, Yoshiteru Sasaki, MD, PhD, Klaus Rajewsky, MD, Anjana Rao, PhD, Martin R Mueller, MD, PhD

Blood (2009) 114 (22): 711.

https://doi.org/10.1182/blood.V114.22.711.711

Published: 2009

Journal Articles

An Assay to Predict L-Asparaginase Neutralization and Enzyme Loaded Red Blood Cells to Maintain in Vivo Efficacy.

Emmanuelle Dufour, Christine Saban-Vianey, Henri Coquelin, Yann Godfrin

Blood (2008) 112 (11): 907.

https://doi.org/10.1182/blood.V112.11.907.907

Published: 2008

Journal Articles

The Relevance of the Inhibitory Receptor FcγIIB for the Regulation of Anti-Factor VIII Antibody Responses in Murine Models.

Christina Hausl, PhD, Pauline M. van Helden, PhD, Rafi U. Ahmad, PhD, Eva M. Muchitsch, PhD, Hans Peter Schwarz, MD, Hartmut Ehrlich, MD, Jan Voorberg, PhD, Birgit M. Reipert, PhD

Blood (2007) 110 (11): 785.

https://doi.org/10.1182/blood.V110.11.785.785

Published: 2007

Journal Articles

WT1 Full Length Protein Vaccination Shows High Immunogenicity and In Vivo Anti-Tumour Activity.

Daniela Cilloni, MD, Ilaria Defilippi, PhD, Paolo Nicoli, MD, Enrico Bracco, PhD, Raffaella Reviglione, PhD, Antonella Roetto, PhD, Alessandro Bondi, PhD, Daniela Di Giovanni, PhD, Erika Decklic, PhD, Elisa Girola, PhD, Rosa Maria Pellegrino, PhD, Francesca Arruga, PhD, Francesca Messa, PhD, Giuseppe Saglio, MD

Blood (2006) 108 (11): 5186.

https://doi.org/10.1182/blood.V108.11.5186.5186

Published: 2006

Journal Articles

Efficient Induction of Tolerance to FIX by Direct Intramuscular Delivery of AAV1.

Ellen F. Cohn, PhD, Meagan E. Kelly, BS, Jiacai Zhuo, MD, Hengjun Chao, MD

Blood (2006) 108 (11): 3287.

https://doi.org/10.1182/blood.V108.11.3287.3287

Published: 2006

Journal Articles

Identification of a Novel Toll-Like Receptor-Independent Immunoadjuvant Pathway That Depends upon Programmed Cell Death.

Kasper Hoebe, PhD, Edith Janssen, PhD, Bruce Beutler, MD.

Blood (2004) 104 (11): 775.

https://doi.org/10.1182/blood.V104.11.775.775

Published: 2004

Journal Articles

In Vivo Visualization of Stat3 Activation in Myeloid Cells during Inflammation and Tumor Growth.

Pedro Horna, MD, Fengdong Cheng, MD, Richard Jove, PhD, Linda Mora, MD, Eduardo M. Sotomayor, MD

Blood (2004) 104 (11): 3434.

https://doi.org/10.1182/blood.V104.11.3434.3434

Published: 2004

NARROW

CYT-0853, a Novel RAD51 Inhibitor, Modulates Immunoregulatory B-Lymphocytes

ZAP-70 Expression in Non Tumoral B Cells: Role in B Tolerance Breakdown?

Targeting Putative Mu Opioid/Chemokine Receptor Type 5 Heteromers Potently Attenuates Nociception in a Murine Model of Sickle Cell Disease

Sustained Elevation of Adenosine-ADORA2B Signaling Promotes Chronic Pain through Neuro-Immune Interaction in Sickle Cell Disease

Preclinical Development Of ROR1 Peptide Based Vaccine With Activity Against Chronic Lymphocytic Leukemia In ROR1 Transgenic Mice

Hepcidin Independent Anemia of Inflammation

Leukemia Free Survival Is Associated with Presence of Leukemia Reactive Antibodies In Allogeneic Transplant Recipients

Tissue Damage and Lymphoma Derived Chemoattractive Signals Impact Regulatory T Cell Trafficking After Allogeneic Hematopoietic Cell Transplantation.

Cannabinoids as Analgesics for Pain in Sickle Cell Disease.

Hyperactivable NFAT1 Ameliorates Autoimmune Encephalitis In Vivo.

An Assay to Predict L-Asparaginase Neutralization and Enzyme Loaded Red Blood Cells to Maintain in Vivo Efficacy.

The Relevance of the Inhibitory Receptor FcγIIB for the Regulation of Anti-Factor VIII Antibody Responses in Murine Models.

WT1 Full Length Protein Vaccination Shows High Immunogenicity and In Vivo Anti-Tumour Activity.

Efficient Induction of Tolerance to FIX by Direct Intramuscular Delivery of AAV1.

Identification of a Novel Toll-Like Receptor-Independent Immunoadjuvant Pathway That Depends upon Programmed Cell Death.

In Vivo Visualization of Stat3 Activation in Myeloid Cells during Inflammation and Tumor Growth.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only